Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scar

Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scar at the site of sternotomy in children with open heart surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201007048955N2

Enrollment

Registered

2020-10-31

Start date

2020-11-21

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar. Hypertrophic scar

Interventions

Intervention 1: Intervention group:Before the induction of surgery and injection of anesthetics and anticoagulants, a certain volume of blood in accordance with patient wound length is taken from the

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Not having diabetes Not having autoimmune disease Not having thrombocytopenia(platelets below 150000) Not receiving glucocorticoids

Exclusion criteria

Exclusion criteria: Patient not referring to the doctor for surveillance Death of the patient during the surveillance period

Design outcomes

Primary

Measure	Time frame
Hypertrophic scar score. Timepoint: 2nd, 12th and 24th weeks after surgery. Method of measurement: Based on Vancouver scar scale(VSS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPouya Pourahmad

Shahid Beheshti University of Medical Sciences

bvbppk@gmail.com0098 26410223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026